Characterization of Matrix‐degrading Proteinases and Their Inhibitors Secreted by Human Gynecological Carcinoma Cells
Open Access
- 1 June 1995
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 86 (6), 568-576
- https://doi.org/10.1111/j.1349-7006.1995.tb02436.x
Abstract
Matrix‐degrading proteinases secreted by tumor cells play crucial roles in tumor cell invasion and metastasis. Serum‐free conditioned media of 7 human gynecological carcinoma cell lines were examined for proteinases and their inhibitors by using gelatin zymography, reverse zymograpby and immunoblotting. All of three ovarian adenocarcinoma cell lines secreted urokinase‐type plasminogen activator. Among them, a mucinous cystadenocarcinoma cell line also secreted tissue‐type plasminogen activator, plasmin‐like enzyme and trypsinogen. On the other hand, two ovarian undifferentiated carcinoma cell lines mainly secreted gelatinase A or B. A choriocarcinoma cell line secreted multiple metalloproteinases in the highest amount, whereas an endometrial adenocarcinoma cell line (HEC‐1) derived from an early clinical stage hardly secreted any gelatinolytic enzyme. The five high proteinases producers hardly secreted the corresponding inhibitors, such as tissue inhibitor of metalloproteinases (TIMP)‐1,‐2 or plasminogen activator inhibitor‐1. In contrast to these highly malignant cell lines, a poor proteinase producer, HEC‐1, secreted a large amount of TIMPs. Therefore, an enhanced proteolytic tendency appears to be associated with gynecological cancer cells established from highly malignant tumors.Keywords
This publication has 40 references indexed in Scilit:
- A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursorNature, 1993
- Activation of TIMP-2/progelatinase a complex by stromelysinBiochemical and Biophysical Research Communications, 1992
- Evaluation of Basement Membrane Components and the 72 kDa Type IV Collagenase in Serous Tumors of the OvaryThe American Journal of Surgical Pathology, 1992
- Type‐1 plasminogen activator inhibitor in human breast carcinomasInternational Journal of Cancer, 1992
- Establishment and characterization of human ovarian clear cell carcinoma cell line, OVISE.The Journal of the Japanese Society of Clinical Cytology, 1992
- Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor‐associated trypsinogenInternational Journal of Cancer, 1991
- Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.The Journal of cell biology, 1989
- Plasminogen activator secretion by established lines of human ovarian carcinoma cells in vitroGynecologic Oncology, 1988
- Invasion potential of human choriocarcinoma cell lines and the role of lytic enzymesGynecologic Oncology, 1985
- Metastatic potential correlates with enzymatic degradation of basement membrane collagenNature, 1980